These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24510833)

  • 21. HIV/AIDS vaccines: 2007.
    Robinson HL
    Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4 responses toward the α4β7-binding V2 loop of HIV gp120 in healthy volunteers.
    Kopycinski J; Cheeseman H; Ashraf A; Gill D; Hayes P; Hannaman D; Gilmour J; Cox JH; Vasan S
    Clin Vaccine Immunol; 2012 Sep; 19(9):1557-9. PubMed ID: 22837097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India.
    Kumar S; Aggarwal P; Vajpayee M; Pandey RM; Seth P
    Vaccine; 2006 Mar; 24(14):2585-93. PubMed ID: 16480792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
    Cristillo AD; Wang S; Caskey MS; Unangst T; Hocker L; He L; Hudacik L; Whitney S; Keen T; Chou TH; Shen S; Joshi S; Kalyanaraman VS; Nair B; Markham P; Lu S; Pal R
    Virology; 2006 Mar; 346(1):151-68. PubMed ID: 16325880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of a multi-gene HIV-1 recombinant subtype CRF02_AG DNA vaccine for expression of multiple immunogenic forms.
    Ellenberger D; Li B; Smith J; Yi H; Folks T; Robinson H; Butera S
    Virology; 2004 Feb; 319(1):118-30. PubMed ID: 14967493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.
    Hopkins R; Bridgeman A; Bourne C; Mbewe-Mvula A; Sadoff JC; Both GW; Joseph J; Fulkerson J; Hanke T
    Eur J Immunol; 2011 Dec; 41(12):3542-52. PubMed ID: 21932450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization.
    Lemiale F; Asefa B; Ye D; Chen C; Korokhov N; Humeau L
    Vaccine; 2010 Feb; 28(8):1952-61. PubMed ID: 20188251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
    Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunological efficiency induced by HIV-1 p24 DNA combined with P24 protein].
    Wang Q; Chen Y; Gao S; Jiang W; Song L; Huang W
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):773-80. PubMed ID: 21845844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials.
    Coupar BE; Purcell DF; Thomson SA; Ramshaw IA; Kent SJ; Boyle DB
    Vaccine; 2006 Feb; 24(9):1378-88. PubMed ID: 16257479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide.
    Huang Y; Chen A; Li X; Chen Z; Zhang W; Song Y; Gurner D; Gardiner D; Basu S; Ho DD; Tsuji M
    Vaccine; 2008 Mar; 26(15):1807-16. PubMed ID: 18329757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens.
    Gómez CE; Nájera JL; Sánchez R; Jiménez V; Esteban M
    Vaccine; 2009 May; 27(24):3165-74. PubMed ID: 19446187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.
    Megede JZ; Otten GR; Doe B; Liu H; Srivastava R; Greer C; Legg H; Tang T; Polo JM; Donnelly JJ; Ulmer JB; Barnett SW
    Vaccine; 2006 Apr; 24(15):2755-63. PubMed ID: 16460840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA electroporation of multi-agent vaccines conferring protection against select agent challenge: TriGrid delivery system.
    Keane-Myers AM; Bell M; Hannaman D; Albrecht M
    Methods Mol Biol; 2014; 1121():325-36. PubMed ID: 24510836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses.
    Newman MJ
    Curr Opin Investig Drugs; 2002 Mar; 3(3):374-8. PubMed ID: 12054082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New hope for an AIDS vaccine.
    Robinson HL
    Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans.
    Bett AJ; Dubey SA; Mehrotra DV; Guan L; Long R; Anderson K; Collins K; Gaunt C; Fernandez R; Cole S; Meschino S; Tang A; Sun X; Gurunathan S; Tartaglia J; Robertson MN; Shiver JW; Casimiro DR
    Vaccine; 2010 Nov; 28(50):7881-9. PubMed ID: 20937317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroporation-mediated intradermal delivery of DNA vaccines in nonhuman primates.
    Adam L; Le Grand R; Martinon F
    Methods Mol Biol; 2014; 1121():309-13. PubMed ID: 24510834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventive HIV-1 vaccines: where are we going?
    Kent SJ
    Int J STD AIDS; 1998 Dec; 9(12):715-9. PubMed ID: 9874116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electroporation-enhanced delivery of nucleic acid vaccines.
    Broderick KE; Humeau LM
    Expert Rev Vaccines; 2015 Feb; 14(2):195-204. PubMed ID: 25487734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.